×
ADVERTISEMENT

Fruzaqla

FDA Approves Fruzaqla in Refractory Metastatic Colorectal Cancer

The FDA approved Fruzaqla for adult patients with metastatic colorectal cancer who received certain prior ...

NOVEMBER 9, 2023

Load more